← ANALYST RATINGS · TIPRANKS

Ufp Technologies (UFPT): analyst forecast and price target

$292 −1.86% close 16.10.26 · market cap $2.3B · Healthcare · Medical - Devices IWM 0.08%
Price targets and ratings of

Analyst consensus

0 Buy0 Hold0 Sell

Ratings of 0 analysts in the last 3 months

12-month forecast

—— upside

Based on 0 price targets given in the last 3 months, the average target is —, the highest —, the lowest —. The average is — from the last price of $292.

$200$250$300Jan 26AprJulOctJan 27AprJulOct
Highest target — Average target — Lowest target —
AnalystFirmPrice target RatingUpsideAction Date Move vs SPY
Unknown Analyst Raymond James — Hold — Reiterated 06.05.26on TipRanks 09:30 +1.3%next day +1.8% · 5 days −0.7%
Max Michaelis★★★★★★★★★★#705 · hits 49% · avg +33.0% Lake Street $289 Buy −0.9% Assigned 06.05.26on TipRanks May 5 10:55 +9.5%next day +1.3% · 5 days +1.8%

The latest rating of each analyst in the last 12 months, as TipRanks lists them. Every rating kept, earlier ones included

Best analysts covering Ufp Technologies

TipRanks picks them by their record on this stock; the figures under the name are their record across all their ratings.

Most accurate

3 months DeepSeek Medical - Devices★★★★★★★★★★TipRanks - DeepSeek · #3482
Hits 50%92 of 185 Average return +5.0%
1 year Max Michaelis★★★★★★★★★★Lake Street · #705
Hits 49%42 of 85 Average return +33.0%
2 years Max Michaelis★★★★★★★★★★Lake Street · #705
Hits 49%42 of 85 Average return +33.0%

Most profitable

3 months DeepSeek Medical - Devices★★★★★★★★★★TipRanks - DeepSeek · #3482
Hits 50%92 of 185 Average return +5.0%
1 year Max Michaelis★★★★★★★★★★Lake Street · #705
Hits 49%42 of 85 Average return +33.0%
2 years Max Michaelis★★★★★★★★★★Lake Street · #705
Hits 49%42 of 85 Average return +33.0%

Recommendation trend

012342Oct 252Nov2Dec3Jan 264Feb4Mar3Apr21May21Jun11JulAugSepOct

Strong BuyBuyHoldSell

Rating05.2606.2607.2608.2609.2610.26
Strong Buy000000
Buy221000
Hold111000
Sell000000

Earnings and sales forecast

Next report: 04.11.26 (Q3 2026, date not confirmed)

Earnings per share

Next quarter’s EPS estimate — $2.48 (from $2.43 to $2.52). Last quarter: $2.68.

Sales

Next quarter’s sales estimate — $167M (from $165M to $168M). Last quarter: $174M.

Best top-analyst consensus in the sector · Healthcare

OVIDOvid Therapeutics
AXGNAxoGen
PTGXProtagonist TherapeuticsStrong Buy
ESTAEstablishment Labs HoldingsStrong Buy
REPLReplimune GroupStrong Buy
About Ufp Technologies
  • CEO: Mitchell C. Rock
  • Employees: 4,846
  • 100 Hale Street, Newburyport, MA, 01950-3504, US
  • www.ufpt.com

UFP Technologies, Inc. specializes in the engineering and custom fabrication of components, subassemblies, finished products, and packaging, primarily utilizing advanced foams, films, and plastics. A significant portion of its business is dedicated to the medical sector, where its single-use and single-patient devices and parts are integral to a broad spectrum of applications, including general medical devices, disposable wound care, infection control, minimally invasive surgical tools, wearable technologies, orthopedic soft goods, and protective packaging for orthopedic implants. Beyond healthcare, the company extends its expertise to the automotive, aerospace and defense, consumer, electronics, and industrial markets. Here, its engineered products and components are incorporated into diverse items such as military uniform and gear, automotive interior trim, athletic padding, sustainable protective packaging, air filtration systems, abrasive nail files, and custom protective cases and inserts. UFP Technologies markets and distributes its offerings across the United States, predominantly through a direct sales force supported by independent manufacturer representatives. The company, established in 1963, is headquartered in Newburyport, Massachusetts.

Data from the stock’s TipRanks forecast page, read 478 min ago. It is read again as soon as a new rating appears and at least every 8 hours. TipRanks ↗